UK Free Trade Agreement is set to boost pharmaceutical and medical device exports by providing procedural flexibility, ...

The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...

India-UK free trade agreement eliminates tariffs on generic drugs and medical devices, boosting Indian exports to the UK market. This opens significant growth opportunities for Indian pharmaceutical ...

The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...

West Pharmaceutical Services (WST) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.52 per share a year ago ...

We primarily deployed the proceeds from selling Nilorn into Havas in the first quarter and into Fortrea during the second ...

Select specialty chemical firms are quietly powering India’s EV revolution. Discover how these behind-the-scenes players are ...

In the latest close session, Recursion Pharmaceuticals (RXRX) was down 1.68% at $6.43. This change lagged the S&P 500's 0.78% gain on the day. Elsewhere, the Dow gained 1.14%, while the tech-heavy ...

Analysts are positive on the Malaysian healthcare sector, driven by its resilient long-term structural growth drivers, ...

The stock needs a compound annual growth rate of 12.2% to double in the next six years. Novo Nordisk can pull it off, especially for those who opt to reinvest the dividend.

This FTA between India and the UK is poised to transform India's export landscape by offering zero-duty market access and a ...